Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
NCT00208923
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Hematologic Malignancies
Interventions
DRUG:
Busulfan, Cyclophosphamide and Fludarabine
Sponsor
Emory University